Clinical Trial Update: 3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of Prostate [NA]

View source ↗

Summary

The clinical trial NCT00429338, sponsored by MD Anderson Cancer Center, evaluating 3T endorectal magnetic resonance spectroscopic imaging for prostate cancer, h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Cancer | NA | Status: TERMINATED